AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Elanco Animal Health Incorporated

$23.28 +$0.76 (+3.37%)
NYSE · 14 Sep 2026 15:18 UTC
Previous Close
$23.17
Day Range
$23.16$23.53
Year Range
$18.22$27.98
Market Cap
11.63B
AVG Volume
6.35M
Trailing/Forward PE
-56.78/18.29
PEG ratio
-4.63
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
0500M1B1.5B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q21.37B
26 Q11.37B
25 Q41.14B
25 Q31.14B
25 Q21.24B
25 Q11.19B
24 Q41.02B
24 Q31.03B
24 Q21.18B
24 Q11.21B
Net Income (USD)
-400M-200M0200M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q254M
26 Q157M
25 Q4-276M
25 Q3-34M
25 Q211M
25 Q167M
24 Q4-8M
24 Q3364M
24 Q2-50M
24 Q132M
Operating Income (USD)
-100M0100M200M300M400M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2109M
26 Q1307M
25 Q419M
25 Q327M
25 Q285M
25 Q1121M
24 Q48M
24 Q3-5M
24 Q2115M
24 Q1133M
EBITDA (USD)
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2274M
26 Q1316M
25 Q46M
25 Q3178M
25 Q2264M
25 Q1274M
24 Q4175M
24 Q3814M
24 Q2195M
24 Q1244M
Cash Flows (USD)
-100M0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2244M
26 Q1-38M
25 Q446M
25 Q3127M
25 Q2180M
25 Q1-69M
24 Q4124M
24 Q3120M
24 Q2166M
24 Q1-22M
EPS (USD)
-1-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.11
26 Q10.11
25 Q4-0.55
25 Q3-0.07
25 Q20.02
25 Q10.13
24 Q4-0.02
24 Q30.73
24 Q2-0.1
24 Q10.06
Expenses (USD)
0200M400M600MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2574M
26 Q1529M
25 Q4493M
25 Q3532M
25 Q2549M
25 Q1500M
24 Q4434M
24 Q3452M
24 Q2477M
24 Q1448M
Cash & Debt (USD)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q2530M
26 Q1428M
25 Q4545M
25 Q3505M
25 Q2539M
25 Q1487M
24 Q4468M
24 Q3490M
24 Q2416M
24 Q1345M
Debt ratios
-20-1001024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Debt ratios by quarter
PeriodDebt ratios
26 Q24.38
26 Q14.66
25 Q44.81
25 Q33.95
25 Q22.4
25 Q12.68
24 Q42.7
24 Q32.84
24 Q2-17.42
24 Q1-18.31
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Margins by quarter
PeriodMargins
26 Q258.33%
26 Q157.26%
25 Q439.34%
25 Q353.39%
25 Q246.49%
25 Q146.61%
24 Q438.14%
24 Q339.32%
24 Q247.13%
24 Q146.22%
Return on Capital
-5%-2.5%0%2.5%5%7.5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Return on Capital by quarter
PeriodReturn on Capital
26 Q20.82%
26 Q10.88%
25 Q4-4.22%
25 Q3-0.5%
25 Q20.16%
25 Q11.05%
24 Q4-0.13%
24 Q35.58%
24 Q2-0.84%
24 Q10.53%
Shares Outstanding
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2499.5M
26 Q1497.7M
25 Q4496.9M
25 Q3496.8M
25 Q2496.6M
25 Q1495.1M
24 Q4494.4M
24 Q3494.3M
24 Q2494.2M
24 Q1493.2M
Book Value Per Share (USD)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q213.19
26 Q113.06
25 Q413.18
25 Q313.58
25 Q213.64
25 Q112.83
24 Q412.33
24 Q313.2
24 Q212.02
24 Q112.28
Total Assets (USD)
05B10B15B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELAN Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q213.56B
26 Q113.22B
25 Q413.36B
25 Q313.55B
25 Q213.74B
25 Q112.94B
24 Q412.61B
24 Q313.28B
24 Q213.76B
24 Q114.02B
Employee Count
02.5K5K7.5K10K20182019202020212022202320242025
ELAN Employee Count by quarter
PeriodEmployee Count
20259.4K
20249K
20239.3K
20229K
20219K
20209.4K
20195.76K
20185.59K
PE Ratio
0100200300400med 32.96Nov 19Mar 20Dec 24Apr 25Jul 25Nov 25Feb 26
ELAN PE Ratio by quarter
PeriodPE Ratio
Feb 26344.72
Feb 26346.79
Feb 26347.76
Jan 26332.3
Jan 26336.72
Jan 26338.51
Jan 26323.89
Jan 26310.78
Dec 25311.88
Dec 25307.74
Dec 25293.8
Dec 25302.22
Nov 25321.13
Nov 25307.05
Nov 25291.04
Nov 25296.56
Oct 2525.34
Oct 2525.23
Oct 2524.51
Oct 2522.61
Oct 2523.62
Sep 2522.44
Sep 2521.97
Sep 2521.2
Sep 2521.09
Aug 2521
Aug 2520.49
Aug 2520.55
Aug 2519.07
Aug 2518.3
Jul 2519.8
Jul 2519.62
Jul 2519.78
Jul 2519.43
Jun 2518.97
Jun 2517.87
Jun 2518.33
Jun 2518.45
May 2517.84
May 2516.8
May 2517.15
May 2515.88
May 2514.26
Apr 2513.84
Apr 2512.35
Apr 2512.61
Apr 2513.38
Mar 2515.23
Mar 2515.4
Mar 2515.27
Mar 2516.29
Feb 2516.34
Feb 2526.57
Feb 2527.13
Feb 2527.78
Jan 2529.01
Jan 2529.13
Jan 2528.98
Jan 2527.56
Jan 2528.89
Dec 2429.08
Dec 2428.04
Dec 2429.18
Dec 2430.14
Nov 2431.85
Nov 2432.21
Nov 2433.71
Nov 2433.93
May 20132.06
Apr 20131.02
Apr 20133.43
Apr 20134.59
Apr 20110.91
Mar 20119.87
Mar 2096.13
Mar 20123.22
Mar 20139.48
Feb 20150.52
Feb 20123.4
Feb 20122.73
Feb 20124.36
Jan 20122.41
Jan 20125.07
Jan 20118.85
Jan 20113.82
Jan 20115.28
Dec 19116.23
Dec 19114.09
Dec 19110.05
Dec 19107.32
Nov 19109.78
Nov 19106.13
Nov 19103.44
Nov 19107.87
Nov 1969.58
Oct 1968.24
Oct 1966.61
Oct 1968.29
Oct 1968.01
Sep 1967.05
Free Cash Flow Yield
2%4%6%8%10%med 3.63%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELAN Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 263.27%
Sep 263.1%
Aug 263.15%
Aug 263.17%
Aug 263.21%
Aug 263.43%
Jul 262.4%
Jul 262.54%
Jul 262.45%
Jul 262.55%
Jul 262.53%
Jun 262.58%
Jun 262.61%
Jun 262.62%
Jun 262.68%
May 262.65%
May 262.91%
May 263.19%
May 262.68%
May 262.54%
Apr 262.51%
Apr 262.41%
Apr 262.47%
Apr 262.48%
Mar 262.47%
Mar 262.38%
Mar 262.49%
Mar 262.45%
Feb 262.16%
Feb 262.92%
Feb 262.9%
Feb 262.89%
Jan 263.03%
Jan 262.99%
Jan 262.97%
Jan 263.1%
Jan 263.24%
Dec 253.22%
Dec 253.27%
Dec 253.42%
Dec 253.33%
Nov 253.13%
Nov 253.27%
Nov 253.46%
Nov 253.39%
Oct 253.23%
Oct 253.24%
Oct 253.34%
Oct 253.62%
Oct 253.46%
Sep 253.65%
Sep 253.72%
Sep 253.86%
Sep 253.88%
Aug 253.9%
Aug 253.99%
Aug 253.98%
Aug 254.29%
Aug 254.99%
Jul 254.62%
Jul 254.66%
Jul 254.62%
Jul 254.7%
Jun 254.82%
Jun 255.12%
Jun 254.99%
Jun 254.96%
May 255.12%
May 255.44%
May 255.33%
May 255.76%
May 258.05%
Apr 258.3%
Apr 259.3%
Apr 259.1%
Apr 258.58%
Mar 257.54%
Mar 257.45%
Mar 257.52%
Mar 257.04%
Feb 257.03%
Feb 256.98%
Feb 256.83%
Feb 256.67%
Jan 256.39%
Jan 256.36%
Jan 256.4%
Jan 256.73%
Jan 256.42%
Dec 246.37%
Dec 246.61%
Dec 246.35%
Dec 246.15%
Nov 245.82%
Nov 245.75%
Nov 245.5%
Nov 245.46%
Nov 246.83%
Oct 246.93%
Oct 246.63%
Price to Sales
0.511.522.53med 2.15Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELAN Price to Sales by quarter
PeriodPrice to Sales
Sep 262.31
Sep 262.44
Aug 262.4
Aug 262.39
Aug 262.36
Aug 262.2
Jul 262.68
Jul 262.53
Jul 262.63
Jul 262.52
Jul 262.54
Jun 262.5
Jun 262.46
Jun 262.46
Jun 262.4
May 262.43
May 262.21
May 262.02
May 262.41
May 262.37
Apr 262.4
Apr 262.5
Apr 262.44
Apr 262.43
Mar 262.44
Mar 262.53
Mar 262.42
Mar 262.46
Feb 262.78
Feb 262.7
Feb 262.72
Feb 262.73
Jan 262.61
Jan 262.64
Jan 262.65
Jan 262.54
Jan 262.44
Dec 252.45
Dec 252.41
Dec 252.3
Dec 252.37
Nov 252.52
Nov 252.41
Nov 252.28
Nov 252.33
Oct 252.45
Oct 252.44
Oct 252.37
Oct 252.19
Oct 252.29
Sep 252.17
Sep 252.13
Sep 252.05
Sep 252.04
Aug 252.03
Aug 251.98
Aug 251.99
Aug 251.85
Aug 251.54
Jul 251.67
Jul 251.65
Jul 251.67
Jul 251.64
Jun 251.6
Jun 251.51
Jun 251.54
Jun 251.55
May 251.5
May 251.42
May 251.44
May 251.34
May 251.09
Apr 251.05
Apr 250.94
Apr 250.96
Apr 251.02
Mar 251.16
Mar 251.17
Mar 251.16
Mar 251.24
Feb 251.24
Feb 251.22
Feb 251.25
Feb 251.28
Jan 251.34
Jan 251.34
Jan 251.33
Jan 251.27
Jan 251.33
Dec 241.34
Dec 241.29
Dec 241.34
Dec 241.39
Nov 241.47
Nov 241.48
Nov 241.55
Nov 241.56
Nov 241.39
Oct 241.37
Oct 241.43
EV/EBITDA
510152025med 9.47Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELAN EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2619.33
Sep 2620.19
Aug 2619.94
Aug 2619.85
Aug 2619.65
Aug 2618.65
Jul 2621.84
Jul 2620.89
Jul 2621.49
Jul 2620.83
Jul 2620.95
Jun 2620.67
Jun 2620.44
Jun 2620.41
Jun 2620.06
May 2620.2
May 2618.82
May 2617.6
May 2620.07
May 2620.3
Apr 2620.47
Apr 2621.11
Apr 2620.73
Apr 2620.69
Mar 2620.73
Mar 2621.31
Mar 2620.6
Mar 2620.89
Feb 2622.98
Feb 2617.88
Feb 2617.96
Feb 2618
Jan 2617.38
Jan 2617.55
Jan 2617.63
Jan 2617.04
Jan 2616.51
Dec 2516.55
Dec 2516.38
Dec 2515.82
Dec 2516.16
Nov 2516.92
Nov 2516.36
Nov 2515.71
Nov 2515.93
Oct 259.61
Oct 259.57
Oct 259.37
Oct 258.83
Oct 259.12
Sep 258.78
Sep 258.65
Sep 258.43
Sep 258.4
Aug 258.37
Aug 258.23
Aug 258.24
Aug 257.82
Aug 257.36
Jul 257.75
Jul 257.7
Jul 257.74
Jul 257.65
Jun 257.53
Jun 257.25
Jun 257.37
Jun 257.4
May 257.24
May 256.98
May 257.07
May 256.74
May 256.07
Apr 255.97
Apr 255.62
Apr 255.68
Apr 255.87
Mar 256.3
Mar 256.34
Mar 256.31
Mar 256.56
Feb 256.57
Feb 256.83
Feb 256.91
Feb 257.01
Jan 257.19
Jan 257.21
Jan 257.19
Jan 256.98
Jan 257.18
Dec 247.21
Dec 247.05
Dec 247.22
Dec 247.36
Nov 247.62
Nov 247.68
Nov 247.9
Nov 247.93
Nov 2311.86
Oct 2311.44
Oct 2311.61
Price/Operating Cashflow
510152025med 16.74Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELAN Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2618.76
Sep 2619.83
Aug 2619.52
Aug 2619.41
Aug 2619.16
Aug 2617.91
Jul 2622.75
Jul 2621.49
Jul 2622.28
Jul 2621.41
Jul 2621.56
Jun 2621.19
Jun 2620.89
Jun 2620.85
Jun 2620.38
May 2620.57
May 2618.74
May 2617.13
May 2620.4
May 2619.97
Apr 2620.19
Apr 2621.01
Apr 2620.52
Apr 2620.48
Mar 2620.52
Mar 2621.28
Mar 2620.36
Mar 2620.73
Feb 2623.43
Feb 2619.73
Feb 2619.85
Feb 2619.9
Jan 2619.02
Jan 2619.27
Jan 2619.37
Jan 2618.54
Jan 2617.79
Dec 2517.85
Dec 2517.61
Dec 2516.82
Dec 2517.3
Nov 2518.38
Nov 2517.57
Nov 2516.66
Nov 2516.97
Oct 2519.23
Oct 2519.14
Oct 2518.6
Oct 2517.16
Oct 2517.92
Sep 2517.03
Sep 2516.67
Sep 2516.09
Sep 2516
Aug 2515.93
Aug 2515.55
Aug 2515.59
Aug 2514.47
Aug 2512.76
Jul 2513.81
Jul 2513.68
Jul 2513.79
Jul 2513.55
Jun 2513.22
Jun 2512.46
Jun 2512.78
Jun 2512.86
May 2512.44
May 2511.72
May 2511.96
May 2511.07
May 258.91
Apr 258.65
Apr 257.71
Apr 257.88
Apr 258.36
Mar 259.51
Mar 259.62
Mar 259.54
Mar 2510.18
Feb 2510.21
Feb 2510.46
Feb 2510.67
Feb 2510.93
Jan 2511.41
Jan 2511.46
Jan 2511.4
Jan 2510.84
Jan 2511.37
Dec 2411.44
Dec 2411.03
Dec 2411.48
Dec 2411.86
Nov 2412.53
Nov 2412.68
Nov 2413.26
Nov 2413.35
Nov 2411.18
Oct 2411.01
Oct 2411.51
Price to Book
0.511.522.5med 1.44Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ELAN Price to Book by quarter
PeriodPrice to Book
Sep 261.76
Sep 261.86
Aug 261.83
Aug 261.82
Aug 261.79
Aug 261.68
Jul 262.02
Jul 261.91
Jul 261.98
Jul 261.9
Jul 261.91
Jun 261.88
Jun 261.85
Jun 261.85
Jun 261.81
May 261.83
May 261.66
May 261.52
May 261.81
May 261.71
Apr 261.73
Apr 261.8
Apr 261.76
Apr 261.75
Mar 261.76
Mar 261.82
Mar 261.74
Mar 261.77
Feb 262
Feb 261.84
Feb 261.85
Feb 261.85
Jan 261.77
Jan 261.8
Jan 261.81
Jan 261.73
Jan 261.66
Dec 251.66
Dec 251.64
Dec 251.57
Dec 251.61
Nov 251.71
Nov 251.64
Nov 251.55
Nov 251.58
Oct 251.62
Oct 251.62
Oct 251.57
Oct 251.45
Oct 251.51
Sep 251.44
Sep 251.41
Sep 251.36
Sep 251.35
Aug 251.35
Aug 251.31
Aug 251.32
Aug 251.22
Aug 251.07
Jul 251.16
Jul 251.15
Jul 251.16
Jul 251.14
Jun 251.11
Jun 251.05
Jun 251.08
Jun 251.08
May 251.05
May 250.99
May 251.01
May 250.93
May 250.79
Apr 250.77
Apr 250.68
Apr 250.7
Apr 250.74
Mar 250.84
Mar 250.85
Mar 250.85
Mar 250.9
Feb 250.91
Feb 250.84
Feb 250.85
Feb 250.87
Jan 250.91
Jan 250.92
Jan 250.91
Jan 250.87
Jan 250.91
Dec 240.91
Dec 240.88
Dec 240.92
Dec 240.95
Nov 241
Nov 241.01
Nov 241.06
Nov 241.07
Nov 241.05
Oct 241.03
Oct 241.08
Elanco Animal Health Incorporated
ELAN
Stockpicker

Video analysis: ELAN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELAN

Squarepoint Ops LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN

defenseworld.net · 13 Sep 2026

Squarepoint Ops LLC Purchases New Position in Elanco Animal Health Incorporated $ELAN

Squarepoint Ops LLC acquired a new position in shares of Elanco Animal Health Incorporated (NYSE: ELAN) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 133,225 shares of the company's stock, valued at approximately $3,279,000. Several other institutional investors and hedge funds

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement

prnewswire.com · 11 Sep 2026

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026.

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

prnewswire.com · 10 Sep 2026

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.

Elanco Director Purchases 40,000 Shares for $936,000

fool.com · 4 Sep 2026

Elanco Director Purchases 40,000 Shares for $936,000

The purchase was valued at $936,000. This investment increased the insider's direct equity position by 27%.

Canada Pension Plan Investment Board Purchases New Holdings in Elanco Animal Health Incorporated $ELAN

defenseworld.net · 1 Sep 2026

Canada Pension Plan Investment Board Purchases New Holdings in Elanco Animal Health Incorporated $ELAN

Canada Pension Plan Investment Board purchased a new position in Elanco Animal Health Incorporated (NYSE: ELAN) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 51,700 shares of the company's stock, valued at approximately $1,272,000. Several other hedge funds and other institutional investors also

348,043 Shares in Elanco Animal Health Incorporated $ELAN Bought by Corient Private Wealth LP

defenseworld.net · 31 Aug 2026

348,043 Shares in Elanco Animal Health Incorporated $ELAN Bought by Corient Private Wealth LP

Corient Private Wealth LP purchased a new stake in shares of Elanco Animal Health Incorporated (NYSE: ELAN) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 348,043 shares of the company's stock, valued at approximately $8,565,000. Corient Private Wealth LP owned approximately

Corient Private Wealth LP Acquires 195,312 Shares of Elanco Animal Health Incorporated $ELAN

defenseworld.net · 31 Aug 2026

Corient Private Wealth LP Acquires 195,312 Shares of Elanco Animal Health Incorporated $ELAN

Corient Private Wealth LP raised its stake in Elanco Animal Health Incorporated (NYSE: ELAN) by 127.9% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 348,043 shares of the company's stock after acquiring an additional 195,312 shares during the

Elanco Animal Health Incorporated $ELAN Shares Sold by Algert Global LLC

defenseworld.net · 28 Aug 2026

Elanco Animal Health Incorporated $ELAN Shares Sold by Algert Global LLC

Algert Global LLC trimmed its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 19.0% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 180,430 shares of the company's stock after selling 42,410 shares during the quarter. Algert Global LLC's holdings

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.